[Effect of cerebrolysin on remyelination processes in multiple sclerosis patients in stage of relapse regression].
Randomized study in people · 2016
- What was studied
- 40 patients during regression of a multiple-sclerosis relapse after steroid treatment
- Main finding
- No between-group EDSS difference was reported; selected functional and neurophysiological measures differed.
Completed treatment · 17/20 (85%) versus 18/20 (90%)
Reported findings and study design
40 patients recovering from an MS relapse: 20 Cerebrolysin versus 20 saline after methylprednisolone 1,000 mg/day for five days. Cerebrolysin 20 mL/day for ten administrations; follow-up 3–4 weeks.
Population or model 40 patients during regression of a multiple-sclerosis relapse after steroid treatment
Dose, route and schedule
After methylprednisolone 1,000 mg/day for five days, the study used Cerebrolysin 20 mL in 200 mL saline once daily for ten administrations, compared with saline. This was sequential adjunctive treatment during recovery from an MS relapse.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Completed treatment | 17/20 (85%) versus 18/20 (90%) | |
| Baseline age | 27.35 (5.65) versus 26.65 (4.93) years | |
| Baseline disease duration | 29.9 (11.01) versus 30.25 (11.98) months | |
| Baseline EDSS | 3.5 [2.0;4.5] versus 3.0 [1.5;4.5] | |
| Follow-up EDSS | 2.0 [1.75;2.5] versus 2.5 [1.75;2.5] | No significant between-group difference · p=0.665 |
| MSFC and SDMT | Greater improvement in the treated group | p=0.038 and p=0.026 |
| Visual test comparison | No significant difference | p=0.658 |
| Neurophysiological abnormality regression | 70.59% versus 27.78% | p=0.028 |
| Neurophysiological deterioration | 10% versus 30% | p=0.228 |
| Gadolinium-positive MRI lesions | 14 before versus 12 afterward | Four treated patients only |
Small short-term comparison. MRI lesion counts from four treated patients cannot establish remyelination or disease modification.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Short follow-up, attrition and a very small MRI subset limit interpretation. Surrogate changes do not establish remyelination.
Source details
Journal publication
Citation and indexed abstract checked. Full methods, funding and risk of bias have not been comprehensively appraised.
Sources checked
Citation
Khabirov FA, Khaybullin TI, Granatov EV, Shakirzianova SR. [Effect of cerebrolysin on remyelination processes in multiple sclerosis patients in stage of relapse regression]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Study source ↗ · DOI 10.17116/jnevro201611612148-53 · Bibliography entry · Link to this summary